4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-011925
Chief Financial Officer sold 1,000 shares at $215.58 ($215,580)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Brett Chief Financial Officer | 2025-04-08 | Sale 10b5-1 | −1,000 | $215.58 | $215,580 | 89,864 | D |
| Open-market sales · 1,000 sh · avg $215.58 · $215,580 | |||||||
Loading xslF345X05/form4.xml…